[June 05, 2013]

World Diabetes Drug Market Prospects Examined in Topical Visiongain Report Now Available at MarketPublishers.com

The world market for diabetes drugs is set to grow from USD 35.6bn in 2012 to reach over USD 55bn by 2017, with its revenues expected to grow further on. The market's growth will be underpinned by rising incidences of type 1 and type 2 diabetes, in line with increasing obesity levels globally and especially in emerging countries such as India and China. Human insulins and analogues will keep their dominance in the overall diabetes treatments marketplace in the long term. Also, rapid uptake of dipeptidyl peptidase (DPP)-4 inhibitors will fuel overall revenue growth.

With companies setting up operations and facilities in developing regions, to capitalise on the surging patient base, the market competition will increase. Eli Lilly, Novo Nordisk, Sanofi, Takeda, Bayer, Merck & C., and Pfizer and Novartis are some of the dominant players in the field.

Topical report "Diabetes Treatments: World Drug Market 2013-2023" prepared by Visiongain (News - Alert) provides an up-clse look at the global market for diabetes treatments from 2013 to 2023. In particular, the study covers:

• global antidiabetic drugs industry's overall sales prospects to 2023;
• revenues to 2023 for 7 world-level submarkets - human insulins and analogues, alpha-glucosidase inhibitors, biguanides, DPP-4 inhibitors, meglitinides, sulphonylureas and thiazolidinediones;
• revenues to 2023 for 25 leading diabetes-treating drugs;
• forecasts to 2023 for the U.S., Japan, Germany, France, the UK, Spain, Italy, Brazil, Russia, India and China;
• review of RnD for treating diabetes;
• discussions and data on top pharma companies;
• interviews with authorities on diabetes treatment;
• overview of the competition and opportunities in the industry;
• analysis of market drivers and restraints;
• prospects for established competitors and firms seeking to enter the sector.

Report Details:

Title: Diabetes Treatments: World Drug Market 2013-2023
Published: April, 2013
Pages: 166
Price: US$ 2,738.00
http://marketpublishers.com/report/diagnostics-diseases/diabetes/diabetes-treatments-world-drug-market-2013-2023.html

Report Contents:

1. EXECUTIVE SUMMARY

1.1 Diabetes Drug Treatments: World Market Review

1.2 Content of the Report Chapters

1.3 Research and Analysis Methods

1.4 Scope of the Report

2. INTRODUCTION TO DIABETES AND ANTIDIABETIC DRUGS

2.1 What is Diabetes?

2.1.1 How is Diabetes Classified?

2.2 Disease Symptoms

…

More topical reports by Visiongain can be found at http://marketpublishers.com/members/visiongain/info.html

[ Back To TMCnet.com's Homepage ]